These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 38353050

  • 21. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K, Saeki H, Nakashima Y, Kamori T, Kawazoe T, Haruta Y, Fujimoto Y, Matsuoka H, Sasaki S, Jogo T, Hirose K, Hu Q, Tsuda Y, Kimura K, Ando K, Oki E, Ikeda T, Maehara Y.
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [Abstract] [Full Text] [Related]

  • 22. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction.
    Han WX, Chen ZM, Wei ZJ, Xu AM.
    World J Surg Oncol; 2016 Nov 03; 14(1):279. PubMed ID: 27809860
    [Abstract] [Full Text] [Related]

  • 23. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H, Chen C, Yue J, Ma M, Ma Z, Yu Z.
    Zhonghua Zhong Liu Za Zhi; 2014 Feb 03; 36(2):141-6. PubMed ID: 24796465
    [Abstract] [Full Text] [Related]

  • 24. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
    Liu F, Zhou R, Jiang F, Liu G, Li K, Zhu G.
    Ann Surg Oncol; 2019 May 03; 26(5):1292-1300. PubMed ID: 30805805
    [Abstract] [Full Text] [Related]

  • 25. Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal.
    Lai H, Zheng J, Zhou G, Li Y.
    J Cancer Res Clin Oncol; 2023 Nov 03; 149(16):14941-14952. PubMed ID: 37606763
    [Abstract] [Full Text] [Related]

  • 26. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May 03; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
    Blank S, Rachakonda S, Keller G, Weichert W, Lordick F, Langer R, Springfeld C, Bruckner T, Becker K, Kumar R, Ott K.
    BMC Cancer; 2014 Feb 03; 14():58. PubMed ID: 24490800
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb 03; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS, Ahn JY, Yook JH, Kim BS.
    World J Surg Oncol; 2017 Jan 18; 15(1):28. PubMed ID: 28100248
    [Abstract] [Full Text] [Related]

  • 38. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
    Chu Y, Xu B, Song Q, Hu Q.
    Clin Transl Oncol; 2021 Jan 18; 23(1):164-171. PubMed ID: 32488805
    [Abstract] [Full Text] [Related]

  • 39. Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study.
    Chen K, Deng X, Yang Z, Yu D, Zhang X, Zhang J, Xie D, He Z, Cheng D.
    Expert Rev Gastroenterol Hepatol; 2020 Aug 18; 14(8):757-764. PubMed ID: 32552040
    [Abstract] [Full Text] [Related]

  • 40. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H, Ooi M, Yu Z, Wang Q, Li Z, Lu Q, Wu Y.
    J Gastrointest Surg; 2019 Feb 18; 23(2):256-263. PubMed ID: 30334176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.